Aug 30, 2026 11:30AM
Aug 30, 2026 11:30AM
Aug 24, 2026 07:30AM
Aug 4, 2026 04:01PM
Aug 4, 2026 04:00PM
Aug 4, 2026 04:00PM
Aug 4, 2026 04:00PM Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher
Jul 27, 2026 06:47AM
Jul 22, 2026 07:30AM
Jul 22, 2026 07:30AM
Jun 22, 2026 12:36PM
Jun 22, 2026 12:33PM
May 26, 2026 10:00AM
May 26, 2026 10:00AM Arrowhead Pharmaceuticals Presents New Positive Clinical Cardiometabolic Data at the 94th European Atherosclerosis Society (EAS) Congress
May 7, 2026 04:01PM
May 1, 2026 07:30AM
May 1, 2026 07:30AM
Apr 24, 2026 06:39AM
Apr 24, 2026 06:39AM
Mar 30, 2026 04:21AM
Mar 28, 2026 10:30AM Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Sess
Mar 26, 2026 02:33PM
Feb 17, 2026 08:30AM
Feb 5, 2026 04:05PM
Jan 7, 2026 07:32AM
Jan 7, 2026 07:30AM
Jan 5, 2026 07:30AM
Jan 5, 2026 07:30AM Arrowhead Pharmaceuticals Announces Health Canada Approval of REDEMPLO™ (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
Dec 22, 2025 07:06AM
Dec 21, 2025 04:00AM
Dec 19, 2025 09:06AM
Dec 2, 2025 07:30AM
Dec 2, 2025 07:30AM
Nov 25, 2025 04:00PM
Nov 19, 2025 09:14AM TD Cowen on Arrowhead Pharma (ARWR): 'Momentum Is Strong; Buy'
Nov 19, 2025 09:06AM
Nov 19, 2025 08:51AM
Nov 18, 2025 11:52AM
Nov 18, 2025 11:52AM
Nov 18, 2025 11:17AM
Oct 24, 2025 08:29AM
Sep 11, 2025 07:30AM Arrowhead files lawsuit against Ionis over plozasiran patent dispute
Sep 11, 2025 07:30AM
Aug 7, 2025 04:01PM
Aug 1, 2025 06:30AM
Aug 1, 2025 06:30AM
Jun 23, 2025 07:30AM
May 13, 2025 04:52AM
May 12, 2025 04:01PM Arrowhead Pharmaceuticals Reports Fiscal 2025 Second Quarter Results
Feb 10, 2025 04:01PM

329,758 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All